Skip to main content

Table 3 post-operative measures

From: Safety and efficacy of Holmium laser enucleation of the prostate (HoLEP) in patients with previous transperineal biopsy (TPB): outcomes from a dual-centre case-control study

 

Group 1

Group 2

Difference (95% CI)

p value

Qmax (mL/sec)

17.3 (±6.7)

22.2 (±15.1)

5.1 (− 4.1, 14.1)

0.264

PVR (mL)

70.9 (±121.6)

63.1 (±84.4)

7.8 (−76.1, 91.7)

0.847

IPSS

6.2 (±4.5)

6.2 (±5.8)

0.1 (−2.9, 2.9)

0.990

Quality of life score

1.0 (±0.8)

1.5 (±1.74)

0.5 (−0.1, 1.1)

0.116

Mean hospital stay (days)

1.3 (1.0)

3.0 (3.6)

1.7 (0.45, 0.77)

< 0.001

  1. CI Confidence intervals, Qmax maximum flow rate, PVR Post-void residual volume, IPSS International Prostate Symptom Score. Data presented as mean (SD).
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us